About Cellares
Cellares develops and operates integrated technologies for automated cell therapy manufacturing and quality control. It offers the Cell Shuttle platform for manufacturing and the Cell Q platform for quality control. Cellares' customers are biopharmaceutical partners who use its services to scale development to industrial production and expand manufacturing capacity.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Series-B+ announced
startupintros.com
- Capital Raise
Raised $257,000,000 · Series-B+
Yahoo Finance
- Capital Raise
Raised $82,000,000 · Series-B+
- Capital Raise
Raised $18,000,000 · Series-A
startupintros.com
- Milestone
Website domain registered
cellares.com
- Milestone
Company founded
South San Francisco, United States
Investors & Backers
Funding History
Founders & Leadership
Ali Soleymannezhad
Chief Commercial Officer
Fabian Gerlinghaus
Co-Founder & CEO
John Tomtishen
VP of Operations
Jonathan Butler
General Counsel & Secretary
Justin McAnear
CFO
Omar Kurdi
Co-Founder & President
Press Coverage & Sources
fundraisingfox.com/companies/cellares
startupintros.com/news/2026-01-28-cellares-series-d
finance.yahoo.com/news/cellares-raises-257-million-series-133000138.html
medcitynews.com/2021/05/cellares-gets-82m-to-make-cell-therapy-manufacturing-automated-scalable/
startupintros.com/news/2020-10-01-cellares-series-a
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com